Candida utilis and Cyberlindnera (Pichia) jadinii: yeast relatives with expanding applications
- 870 Downloads
The yeast Candida utilis is used as a food additive and as a host for heterologous gene expression to produce various metabolites and proteins. Reliable protocols for intracellular production of recombinant proteins are available for C. utilis and have now been expanded to secrete proteins into the growth medium or to achieve surface display by linkage to a cell wall protein. A recombinant C. utilis strain was recently shown to induce oral tolerance in a mouse model of multiple sclerosis suggesting future applications in autoimmune therapy. Whole genome sequencing of C. utilis and its presumed parent Cyberlindnera (Pichia) jadinii demonstrated different ploidy but high sequence identity, consistent with identical recombinant technologies for both yeasts. C. jadinii was recently described as an antagonist to the important human fungal pathogen Candida albicans suggesting its use as a probiotic agent. The review summarizes the status of recombinant protein production in C. utilis, as well as current and future biotechnological and medical applications of C. utilis and C. jadinii.
KeywordsCandida utilis Torula Cyberlindnera jadinii Pichia jadinii Candida albicans Heterologous gene expression Secretion Surface display Immunological tolerance
The work in the laboratory of the authors was funded in part by the Cluster of Industrial Biotechnology NRW CLIB2021.
Compliance with ethical standards
This article does not contain any studies with human participants or animals performed by any of the authors.
Conflict of interest
The authors declare that they have no conflict of interest.
- Bekatorou A, Psaríanos C, Koutinas AA (2006) Production of food grade yeasts. Food Technol Biotechnol 44:407–415Google Scholar
- Eisenhaber B, Schneider G, Wildpaner M, Eisenhaber F (2004) A sensitive predictor for potential GPI lipid modification sites in fungal protein sequences and its application to genome-wide studies for Aspergillus nidulans, Candida albicans, Neurospora crassa, Saccharomyces cerevisiae and Schizosaccharomyces pombe. J Mol Biol 337:243–253CrossRefPubMedGoogle Scholar
- Frieman MB, Cormack BP (2004) Multiple sequence signals determine the distribution of glycosylphosphatidylinositol proteins between the plasma membrane and cell wall in Saccharomyces cerevisiae. Microbiologica 150:3105–3114Google Scholar
- Gellissen G, Kunze G, Gaillardin C, Cregg JM, Berardi E, Veenhuis M, van der Klei I (2005) New yeast expression platforms based on methylotrophic Hansenula polymorpha and Pichia pastoris and on dimorphic Arxula adeninivorans and Yarrowia lipolytica—a comparison. FEMS Yeast Res 5:1079–1096CrossRefPubMedGoogle Scholar
- Henneberg W (1926) Handbuch der Gärungsbakteriologie, 2. Aufl. Bd.2. Paul Parey, BerlinGoogle Scholar
- Kondo K, Saito T, Kajiwara S, Takagi M, Misawa N (1995) A transformation system for the yeast Candida utilis: use of a modified endogenous ribosomal protein gene as a drug-resistant marker and ribosomal DNA as an integration target for vector DNA. J Bacteriol 177:7171–7177PubMedPubMedCentralGoogle Scholar
- Kurtzman R, Basehoar-Powers (2011) The yeasts—a taxonomic study, vol. 1, 5 edn. Elsevier, London, Burlington, San DiegoGoogle Scholar
- Mukherjee PK, Chandra J, Retuerto M, Sikaroodi M, Brown RE, Jurevic R, Salata RA, Lederman MM, Gillevet PM, Ghannoum MA (2014) Oral mycobiome analysis of HIV-infected patients: identification of Pichia as an antagonist of opportunistic fungi. PLoS Pathog 10:e1003996CrossRefPubMedPubMedCentralGoogle Scholar
- Rupp O, Brinkrolf K, Buerth C, Kunigo M, Schneider J, Jaenicke S, Goesmann A, Pühler A, Jaeger KE, Ernst JF (2015) The structure of the Cyberlindnera jadinii genome and its relation to Candida utilis analyzed by the occurrence of single nucleotide polymorphisms. J Biotechnol 211:20–30CrossRefPubMedGoogle Scholar
- Thévenot J, Cordonnier C, Rougeron A, Le Goff O, Nguyen HT, Denis S, Alric M, Livrelli V, Blanquet-Diot S (2015) Enterohemorrhagic Escherichia coli infection has donor-dependent effect on human gut microbiota and may be antagonized by probiotic yeast during interaction with Peyer’s patches. Appl Microbiol Biotechnol 99:9097–9110CrossRefPubMedGoogle Scholar
- Thompson AL, Johnson BT, Sempowski GD, Gunn MD, Hou B, DeFranco AL, Staats HF (2012) Maximal adjuvant activity of nasally delivered IL-1α requires adjuvant-responsive CD11c(+) cells and does not correlate with adjuvant-induced in vivo cytokine production. J Immunol 188:2834–2846CrossRefPubMedPubMedCentralGoogle Scholar